Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence

Marc Luginbühl, Frederike Stöth, Alexandra Schröck, Stefan Gaugler, Wolfgang Weinmann

Published: 2020-12-06 DOI: 10.1038/s41596-020-00416-x

AI 解读

Generation of mouse–human chimeric embryos

Genome-wide quantification of transcription factor binding at single-DNA-molecule resolution using methyl-transferase footprinting

Generation of CRISPR–Cas9-mediated genetic knockout human intestinal tissue–derived enteroid lines by lentivirus transduction and single-cell cloning

A puromycin-dependent activity-based sensing probe for histochemical staining of hydrogen peroxide in cells and animal tissues

Decoding personal biotic and abiotic airborne exposome

A clinically relevant model of focal embolic cerebral ischemia by thrombus and thrombolysis in rhesus monkeys

Bioengineering human intestinal mucosal grafts using patient-derived organoids, fibroblasts and scaffolds

Biomimetic tail-to-head terpene cyclizations using the resorcin[4]arene capsule catalyst

Neuroscience robotics for controlled induction and real-time assessment of hallucinations

Scanorama: integrating large and diverse single-cell transcriptomic datasets

Single-cell RNA sequencing (scRNA-seq)（单细胞RNA测序）

Data integration（数据集成）

Heterogeneity（异质性）

查看全部

Sections

Figures

References

Phosphatidylethanol (PEth), which is formed by enzymatic reaction between ethanol and phosphatidylcholine, is a direct marker for alcohol usage. PEth has a long elimination half-life (~5–nobreak10 d) and specimens can be sampled using mini
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
- Reporting Summary
- References
References
ACKNOWLEDGMENTS

Varga, A., Hansson, P., Johnson, G. & Alling, C. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin. Chim. Acta 299, 141–150 (2000).
Gnann, H. et al. Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS/MS. Anal. Bioanal. Chem. 396, 2415–2423 (2010).
Simon, T. W. Providing context for phosphatidylethanol as a biomarker of alcohol consumption with a pharmacokinetic model. Regul. Toxicol. Pharmacol. 94, 163–171 (2018).
Javors, M. A., Hill-Kapturczak, N., Roache, J. D., Karns-Wright, T. E. & Dougherty, D. M. Characterization of the pharmacokinetics of phosphatidylethanol 16:0/18:1 and 16:0/18:2 in human whole blood after alcohol consumption in a clinical laboratory study. Alcohol. Clin. Exp. Res. 40, 1228–1234 (2016).
Luginbühl, M., Weinmann, W., Butzke, I. & Pfeifer, P. Monitoring of direct alcohol markers in alcohol use disorder patients during withdrawal treatment and successive rehabilitation. Drug Test. Anal. 11, 859–869 (2019).
Faller, A. et al. Stability of phosphatidylethanol species in spiked and authentic whole blood and matching dried blood spots. Int. J. Legal Med. 127, 603–610 (2013).
Kummer, N. et al. Quantification of phosphatidylethanol 16:0/18:1, 18:1/18:1, and 16:0/16:0 in venous blood and venous and capillary dried blood spots from patients in alcohol withdrawal and control volunteers. Anal. Bioanal. Chem. 408, 825–38 (2016).
Luginbühl, M., Gaugler, S. & Weinmann, W. Fully automated determination of phosphatidylethanol 16:0/18:1 and 16:0/18:2 in dried blood spots. J. Anal. Toxicol. 43, 489–496 (2019).
Tanna, S. & Lawson, G. Self-sampling and quantitative analysis of DBS: can it shift the balance in over-burdened healthcare systems? Bioanalysis 7, 1963–1966 (2015).
Luginbühl, M., et al. Variation in the relative isomer abundance of synthetic and biologically derived phosphatidylethanols and its consequences for reliable quantification. J. Anal. Toxicol. http://doi.org/10.1093/jat/bkaa034 (2020).
Schröck, A., Wurst, F. M., Thon, N. & Weinmann, W. Assessing phosphatidylethanol (PEth) levels reflecting different drinking habits in comparison to the alcohol use disorders identification test–C (AUDIT-C). Drug Alcohol Depend. 178, 80–86 (2017).
Schröck, A., Pfäffli, M., König, S. & Weinmann, W. Application of phosphatidylethanol (PEth) in whole blood in comparison to ethyl glucuronide in hair (hEtG) in driving aptitude assessment (DAA). Int. J. Legal Med. 130, 1527–1533 (2016).
Schröck, A., Thierauf-Emberger, A., Schürch, S. & Weinmann, W. Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol—a drinking study with 16 volunteers. Int. J. Legal Med. 131, 153–160 (2017).
Schröck, A., Thierauf, A., Wurst, F. M., Thon, N. & Weinmann, W. Progress in monitoring alcohol consumption and alcohol abuse by phosphatidylethanol. Bioanalysis 6, 2285–2294 (2014).
Luginbühl, M., Willem, S., Schürch, S. & Weinmann, W. Formation of phosphatidylethanol from endogenous phosphatidylcholines in animal tissues from pig, calf, and goat. Forensic Sci. Int. 283, 211–218 (2018).
Luginbuhl, M. & Gaugler, S. The application of fully automated dried blood spot analysis for liquid chromatography-tandem mass spectrometry using the CAMAG DBS-MS 500 autosampler. Clin. Biochem. 82, 33–39 (2020).
Andresen-Streichert, H. et al. Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study. Transpl. Int. 30, 611–620 (2017).
Fleming, M. F. et al. Phosphatidylethanol detects moderate-to-heavy alcohol use in liver transplant recipients. Alcohol. Clin. Exp. Res. 41, 857–862 (2017).
Schröck, A., Hernández Redondo, A., Martin Fabritius, M., König, S. & Weinmann, W. Phosphatidylethanol (PEth) in blood samples from “driving under the influence” cases as indicator for prolonged excessive alcohol consumption. Int. J. Legal Med. 130, 393–400 (2016).
Ulwelling, W. & Smith, K. The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines. J. Forensic Sci. 63, 1634–1640 (2018).
Helander, A. & Hansson, T. National harmonization of the alcohol biomarker PEth. Lakartidningen 110, 1747–1748 (2013).
World Anti-Doping Agency. WADA Technical Document TD2019DL v. 2.0. http://www.wada-ama.org/sites/default/files/resources/files/td2019dl_v2_finalb.pdf (2019).
Cowan, J. M., Weathermon, A., McCutcheon, J. R. & Oliver, R. D. Determination of volume of distribution for ethanol in male and female subjects. Anal. Toxicol. 20, 287–290 (1996).
Wurst, F. M. et al. Ethanol metabolites: their role in the assessment of alcohol intake. Alcohol. Clin. Exp. Res. 39, 2060–2072 (2015).
Hartmann, S. et al. Phosphatidylethanol as a sensitive and specific biomarker—comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict. Biol. 12, 81–84 (2007).
Stewart, S. H., Koch, D. G., Willner, I. R., Anton, R. F. & Reuben, A. Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol. Clin. Exp. Res. 38, 1706–1711 (2014).
Afshar, M. et al. Cut-point levels of phosphatidylethanol to identify alcohol misuse in a mixed cohort including critically ill patients. Alcohol. Clin. Exp. Res. 41, 1745–1753 (2017).
Aradottir, S., Asanovka, G., Gjerss, S., Hansson, P. & Alling, C. Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol. 41, 431–437 (2006).
Luginbühl, M., Bekaert, B., Suesse, S. & Weinmann, W. Detox shampoos for EtG and FAEE in hair—results from in vitro experiments. Drug Test. Anal. 11, 870–877 (2019).
Luginbühl, M., Nussbaumer, S. & Weinmann, W. Decrease of ethyl glucuronide concentrations in hair after exposure to chlorinated swimming pool water. Drug Test. Anal. 10, 689–693 (2018).
Reisfield, G. M. et al. The roles of phosphatidylethanol (PEth), ethyl glucuronide (EtG), and ethyl sulfate (EtS) in identifying alcohol consumption among participants in professionals’ health programs. Drug Test. Anal. 12, 1102–1108 (2020).
Jones, J., Jones, M., Plate, C. & Lewis, D. The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots. Anal. Methods 3, 1101–1106 (2011).
Wang, E. J., et al. HemaApp: noninvasive blood screening of hemoglobin using smartphone cameras. in UbiComp 2016—Proceedings of the 2016 ACM International Joint Conference on Pervasive and Ubiquitous Computing 593–604 (2016).
Capiau, S., Wilk, L. S., De Kesel, P. M. M., Aalders, M. C. G. & Stove, C. P. Correction for the hematocrit bias in dried blood spot analysis using a nondestructive, single-wavelength reflectance-based hematocrit prediction method. Anal. Chem. 90, 1795–1804 (2018).
Oostendorp, M., El Amrani, M., Diemel, E. C., Hekman, D. & Van Maarseveen, E. M. Measurement of hematocrit in dried blood spots using near-infrared spectroscopy: robust, fast, and nondestructive. Clin. Chem. 62, 1534–1536 (2016).
Velghe, S., Delahaye, L. & Stove, C. P. Is the hematocrit still an issue in quantitative dried blood spot analysis? J. Pharm. Biomed. Anal. 163, 188–196 (2019).
Abu-Rabie, P., Denniff, P., Spooner, N., Chowdhry, B. Z. & Pullen, F. S. Investigation of different approaches to incorporating internal standard in DBS quantitative bioanalytical workflows and their effect on nullifying hematocrit-based assay bias. Anal. Chem. 87, 4996–5003 (2015).
Schröck, A., Henzi, A., Bütikofer, P., König, S. & Weinmann, W. Determination of the formation rate of phosphatidylethanol by phospholipase D (PLD) in blood and test of two selective PLD inhibitors. Alcohol 73, 1–7 (2018).
Thompson, P. M. et al. Phosphatidylethanol in postmortem brain and serum ethanol at time of death. Alcohol. Clin. Exp. Res. 40, 2557–2562 (2016).
Weinmann, W., Schröck, A. & Wurst, F. M. Commentary on the paper of Thompson P. et al.: Phosphatidylethanol in postmortem brain and serum ethanol at time of death. Alcohol. Clin. Exp. Res. 41, 501–503 (2017).
Gustavsson, L. & Alling, C. Formation of phosphatidylethanol in rat brain by phospholipase D. Biochem. Biophys. Res. Commun. 142, 958–963 (1987).
Gomez-Cambronero, J. and Henkels, K. M. in Encyclopedia of Signaling Molecules (ed. Choi, S.) 3999–4010 (Springer International Publishing, 2018).
Gu, H., Liu, G., Wang, J., Aubry, A.-F. & Arnold, M. E. Selecting the correct weighting factors for linear and quadratic calibration curves with least-squares regression algorithm in bioanalytical LC-MS/MS assays and impacts of using incorrect weighting factors on curve stability, data quality, and assay performance. Anal. Chem. 86, 8959–8966 (2014).
US Food and Drug Administration. Bioanalytical Method Validation: Guidance for Industry. http://www.fda.gov/media/70858/download (2018).

Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence

Supplementary information

Reporting Summary

推荐阅读